GO
Loading...

Enter multiple symbols separated by commas

Alzheimer's Drug Could Save U.S. Trillions, New Study Says

A new study says if a drug is quickly developed that delays the onset of Alzheimer's Disease it would save the U.S. economy trillions of dollars.

The group, which goes by the acronym ACT-AD, claims this is the first economic estimate of the impact new drugs could have.

The results show that if an Alzheimer's treatment were to come to market by 2010--and if the drug delayed the onset of the disease by up to five years--the American economy could save nearly $4 trillion by 2050.

Nearly five million people in the U.S. have Alzheimer's but that number is forecast to possibly triple by mid-century.

The group that did the study gets some of its funding from Wyeth, Elan and MyriadGenetics, all of which are working on Alzheimer's treatments. Many other companies also have Alzheimer's drugs in development.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • CNBC update: Oldest human body part

    President Obama became the first sitting President to visit Kenya and Ethiopia; Joyce Mitchell has pleaded guilty to helping two prison inmates escape; and archaeology students in France have discovered what seems to be the oldest human body part ever found, reports CNBC's Sue Herera.

  • FMHR portfolio: Trader out of BP, in on MPC

    JIm Lebenthal of Lebenthal Asset Management, explains his move out of BP and into Marathon Petroleum.

  • Baidu CEO Robin Li on China

    Robin Li, Baidu's CEO, spoke about investing in China at last week's DCM Ventures CEO Summit in San Francisco.